INHIBRX BIOSCIENCES, INC.

INBX ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2025

Total Assets: $146.5M

Liabilities Breakdown FY2025

Total Liabilities: $138.5M